Efficacy of short-term nivolumab treatment in a Chinese patient with relapsed advanced-stage lung squamous cell carcinoma: A case report

INTRODUCTION: Currently, the options are limited for the treatment of patients who have failed 2 lines of chemotherapy for advanced lung squamous cell carcinoma (SCC). Recently, nivolumab, a fully human IgG4 programmed death 1 immune checkpoint inhibitor antibody, was approved to treat patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Guoliang, He, Hanping, Bi, Jianping, Li, Ying, Li, Yanping, Zhang, Yong, Wang, Mingwei, Han, Guang, Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059083/
https://www.ncbi.nlm.nih.gov/pubmed/27749580
http://dx.doi.org/10.1097/MD.0000000000005077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059083/
https://www.ncbi.nlm.nih.gov/pubmed/27749580
http://dx.doi.org/10.1097/MD.0000000000005077

Ejemplares similares